Navigation Links
PCI Appoints John Davis, PE, to Board
Date:3/14/2013

Raleigh, NC (PRWEB) March 14, 2013

PCI, a leading provider of calibration and maintenance services to the Life Sciences industry is pleased to announce the recent appointment of John Davis, PE, to the PCI Board. Mr. Davis has been a leader in the biotech and pharmaceutical industries for 30 years. He has proven his skills as a leader at various pharmaceutical companies and equally demonstrated his ability to lead as an entrepreneur.

PCI is experiencing exciting growth, with new locations and an increasing client list. The Board plays an integral part, ensuring the PCI success philosophy will positively impact new and existing clients. “PCI is thrilled to have John join our Board. John brings a unique perspective with his consulting company experience and his experience in senior management with large pharmaceutical and biotech operating companies,” said Andy Ferrell, PCI CEO.

Mr. Davis was the founder and president of Serentec, Inc., an international pharmaceutical services firm that was subsequently acquired by Lloyd’s Register in 2002. Currently Associate Director, IT at Biogen Idec, Mr. Davis’ career included leadership and technical roles with Eisai, Glaxo Wellcome, Burroughs-Wellcome, Fluor Daniel and Pitman Moore. He has been involved in IT, process automation, systems design, implementation and validation in the biotech and pharmaceutical industries since 1982.

Earning his B.S. degree in Chemistry from Indiana State University, Mr. Davis is a registered professional engineer and received his MBA from UNC’s Kenan-Flagler School of Business. “I am excited to join the PCI Board. It will be a rewarding experience to be part of such a successful and driven company,” said Mr. Davis.

To see more on the PCI Board Members, visit http://www.pci-llc.com/about/pci-leadership-team/.

About PCI:
PCI was founded in 1996 with a vision of becoming the best consulting and technical services firm in the life sciences industry. The company’s core expertise is calibration and maintenance compliance for FDA-regulated manufacturing facilities and laboratories. PCI’s mission is to provide personalized customer service, exceptional and quality documentation to their customers while always preserving the integrity and ingenuity of performance. The company places high value on honesty, integrity, pride, self-esteem and teamwork. PCI take these values and mission as their primary focus in creating the ultimate result for clients: total compliance in the product quality life cycle.

PCI offers a comprehensive selection of quality services that include Calibration & Maintenance Consulting, Process & Analytical Equipment Calibrations, and ISO 17025 accredited Metrology Laboratory. The company’s six regional offices are located in Boston, Gaithersburg, Indianapolis, Raleigh, San Francisco and Seattle.

To learn more about PCI and its services, visit http://www.pci-llc.com/.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10526855.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. California Healthcare Institute Appoints Vice President-State Government Affairs
2. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
3. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
4. Creabilis Appoints Catherine Moukheibir to its Board of Directors
5. Verenium Appoints Holger Liepmann To Its Board Of Directors
6. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
7. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
8. Avantium Appoints Jonathan Wolfson to its Supervisory Board
9. Sutro Biopharma Appoints Edward C. Albini as Chief Financial Officer
10. PCI Appoints Jose Solorio-Ruiz, MBA, Manager of West Coast Operations
11. Advanced Cell Diagnostics Appoints Evangeline Gonzalez as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... 2017   KCNQ2 Cure Alliance  and ... today announced that they have completed the first ... implicated in KCNQ2 epileptic encephalopathy. They also report ... case involving an additional KCNQ2 genetic mutation. ... Pairnomix entered into a collaboration to further explore ...
(Date:7/18/2017)... ... July 18, 2017 , ... Genedata, a ... leading science and technology company, has implemented Genedata Biologics ™ to scale-up ... of Oncology, Immunology, and Neurodegenerative Diseases. , The need to systematically evaluate large ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... drug delivery device testing capabilities to encompass the full series of ISO 80369 ... evaluations of fittings for medical device and drug delivery systems. With this recent ...
(Date:7/17/2017)... ... 2017 , ... Panitch Schwarze Belisario & Nadel ... (Biomedical Innovation Group) annual meeting in China. , This year’s meeting, held June ... therapy, a rapidly developing highly personalized anti-cancer technology that involves removing some of ...
Breaking Biology Technology:
(Date:5/23/2017)... May 23, 2017  Hunova, the first robotic gym for the rehabilitation ... officially launched in Genoa, Italy . The first 30 ... and the USA . The technology was developed and ... by the IIT spin-off Movendo Technology thanks to a 10 million euro ... Release, please click: ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
Breaking Biology News(10 mins):